Merck & Co., Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4426
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Merck & Co., Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Merck & Co., Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Merck & Co., Inc. (Merck & Co. or ‘the company’), known as Merck Sharp & Dohme (MSD) outside the US and Canada, is a healthcare company. The company delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The company sells prescription medicine and pharmaceutical products for the treatment of cardiovascular, cancer, immune disorders, infectious, respiratory and women’s diseases, and diabetes. It commercializes products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It also sells Vaccine products that include preventive pediatric, adolescent and adult vaccines to physicians, wholesalers, physician distributors and government entities. Apart from this, Merck & Co. manufactures and markets animal health products, including vaccines and sells to veterinarians, distributors and animal producers. The company has operations across the world. Merck & Co. is headquartered in Kenilworth, New Jersey, the US.

Scope

- Detailed information on Merck & Co., Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Merck & Co., Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Merck & Co., Inc. including a breakdown and examination of key business segments
- Intelligence on Merck & Co., Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Merck & Co., Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Merck & Co., Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Merck & Co., Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Merck & Co., Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Merck & Co., Inc.: Company Overview 9
Merck & Co., Inc.: Overview and Key Facts 9
Merck & Co., Inc.: Overview 9
Merck & Co., Inc.: Key Facts 9
Merck & Co., Inc.: Key Employees 11
Merck & Co., Inc.: Key Employee Biographies 13
Merck & Co., Inc.: Major Products and Services 15
Merck & Co., Inc.: Company History 18
Merck & Co., Inc.: Management Statement 29
Merck & Co., Inc.: Locations and Subsidiaries 33
Merck & Co., Inc.: Key Competitors 34
Merck & Co., Inc.: Company Analysis 35
Merck & Co., Inc.: Business Description 35
Merck & Co., Inc.: SWOT Analysis 36
Merck & Co., Inc.: SWOT Overview 36
Merck & Co., Inc.: Strengths 36
Merck & Co., Inc.: Weaknesses 37
Merck & Co., Inc.: Opportunities 37
Merck & Co., Inc.: Threats 38
Merck & Co., Inc.: Corporate Financial Deals Activity 40
Merck & Co., Inc.: Financial Deals Overview 40
Merck & Co., Inc.: Targets and Partners 42
Merck & Co., Inc.: Top Deals 2014 – 2018YTD* 45
Merck & Co., Inc.: Advisors 46
Merck & Co., Inc.: Top Legal Advisors 46
Merck & Co., Inc.: Top Financial Advisors 46
Merck & Co., Inc.: Mergers and Acquisitions 47
Merck & Co., Inc.: Corporate Venturing 48
Merck & Co., Inc.: Partnership 49
Merck & Co., Inc.: Divestments 50
Merck & Co., Inc.: Recent Developments 51
Merck & Co., Inc.: News and Events Summary 51
Merck & Co., Inc.: Contracts 55
Merck & Co., Inc.: Financial Deals 56
Merck & Co., Inc.: Financial Performance 57
Merck & Co., Inc.: Regulatory and Legal Events 57
Merck & Co., Inc.: Strategy and Operations 58
Appendix 59
Contact Us 59
Methodology 59
About MarketLine 60

List of Tables
Table 1: Merck & Co., Inc.: Key Facts
Table 2: Merck & Co., Inc.: Key Employees
Table 3: Merck & Co., Inc.: Locations and Subsidiaries
Table 4: Merck & Co., Inc.: Key Competitors
Table 5: Merck & Co., Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Merck & Co., Inc.: M&A Activity by Geography (TTM*)
Table 7: Merck & Co., Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Merck & Co., Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Merck & Co., Inc.: Targets and Partners
Table 10: Merck & Co., Inc.: Top Deals 2014 - 2018YTD*
Table 11: Merck & Co., Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Merck & Co., Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Merck & Co., Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Merck & Co., Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Merck & Co., Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Merck & Co., Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Merck & Co., Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 18: Merck & Co., Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 19: Merck & Co., Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 20: Merck & Co., Inc.: Divestments by Geography (2014 - YTD*2018)
Table 21: Merck & Co., Inc.: News and Events Summary
Table 22: Merck & Co., Inc.: Contracts
Table 23: Merck & Co., Inc.: Financial Deals
Table 24: Merck & Co., Inc.: Financial Performance
Table 25: Merck & Co., Inc.: Regulatory and Legal Events
Table 26: Merck & Co., Inc.: Strategy and Operations

List of Figures
Figure 1: Merck & Co., Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Merck & Co., Inc.: M&A Activity by Geography (TTM*)
Figure 3: Merck & Co., Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Merck & Co., Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Merck & Co., Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Merck & Co., Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Merck & Co., Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Merck & Co., Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Merck & Co., Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Merck & Co., Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Merck & Co., Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 12: Merck & Co., Inc.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Merck & Co., Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Herantis Pharma Plc (HRTIS):企業の財務・戦略的SWOT分析
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …
  • Petronas Dagangan Berhad (PETDAG):企業の財務・戦略的SWOT分析
    Petronas Dagangan Berhad (PETDAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Elders Limited:企業のM&A・事業提携・投資動向
    Elders Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Elders Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Milestone Scientific Inc (MLSS):製品パイプライン分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments. The company provides medical products and dental products. Its medical products include epidurals, intra-articular injections, …
  • DiaSorin SpA (DIA):企業の財務・戦略的SWOT分析
    DiaSorin SpA (DIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • NMDC Ltd:企業のM&A・事業提携・投資動向
    NMDC Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NMDC Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • MISC Berhad (MISC):石油・ガス:M&Aディール及び事業提携情報
    Summary MISC Bhd (MISC), a subsidiary of Petroliam Nasional Berhad (Petronas), is an international energy shipping and maritime conglomerate. The company is a fully integrated maritime, offshore floating solution, heavy engineering and logistics service provider. Its principal business activities in …
  • W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary W&T Offshore Inc (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and of …
  • Eng Kah Corporation Berhad:企業の戦略・SWOT・財務情報
    Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Wanhua Chemical Group Co Ltd (600309):企業の財務・戦略的SWOT分析
    Wanhua Chemical Group Co Ltd (600309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Seven-Eleven Japan Co., Ltd.:企業の戦略・SWOT・財務情報
    Seven-Eleven Japan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven-Eleven Japan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Arsenal Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Arsenal Medical Inc (Arsenal) is a medical technology company that develops polymer based foams and fibers. The company’s products comprise foam system for acute hemorrhage and DARPA collaboration products. Its foam system is an in-situ foaming foams, which is designed for the control of sev …
  • ManpowerGroup Inc (MAN):企業の財務・戦略的SWOT分析
    ManpowerGroup Inc (MAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • National Gas & Industrial Co (2080):企業の財務・戦略的SWOT分析
    National Gas & Industrial Co (2080) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tillotts Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Tillotts Pharma AG (Tillotts), a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products are used for the treatment of var …
  • Oasis Diagnostics Corp:企業の製品パイプライン分析2018
    Summary Oasis Diagnostics Corp (Oasis Diagnostics) is a medical device company that develops and commercializes tools for non-invasive diagnosis and detection of diseases. The company's products include saliva DNA isolation kit, genomic kit and immunoassay products, among others. Its saliva DNA isol …
  • De La Rue Plc (DLAR):企業の財務・戦略的SWOT分析
    De La Rue Plc (DLAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Newfield Exploration Company (NFX)-石油・ガス分野:企業M&A・提携分析
    Summary Newfield Exploration Company (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The com …
  • 908 Devices Inc:医療機器:M&Aディール及び事業提携情報
    Summary 908 Devices Inc (908 Devices) is a manufacturer of handheld chemical detection tools, tiny footprint analyzers and fast separation devices. The company’s product portfolio includes MX908, a second-generation tool that leverages high-pressure mass spectrometry (HPMS); M908 focuses on priority …
  • Long Run Exploration Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Long Run Exploration Ltd (Long Run), formerly WestFire Energy Ltd, a subsidiary of Calgary Sinoenergy Investment Corp, is an oil and gas company that offers development and exploration of light oil. The company grows crude oil volumes within its diversified portfolio properties. Its oil expl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆